Skip to main content
. 2021 Dec 17;163(7):1313–1323. doi: 10.1097/j.pain.0000000000002513

Table 1.

Baseline demographic and clinical characteristics.

Social learning group (n = 22) Control group (n = 22) Overall Difference (P, χ2)
Demographic characteristics
 Age 61.91 (12.86) 63.75 (12.67)1) 62.79 1.84 (F = 0.22, P = 0.64)
 Sex: Female 13 (59.09%) 14 (63.64%) 61.36% 4.55% (χ2 = 0.1, P = 0.76)
Clinical characteristics
 Back pain duration in total (mo) 151 (154.59) 180.05 (140.12) 165.52 29.05 (F = 0.43, P = 0.52)
 Back pain duration of current intensity (mo) 57.36 (53.74) 97.68 (84.60) 77.52 40.32 (F = 3.56, P = 0.07)
 Disability caused by back pain 6.14 (2.71) 6.05 (2.77) 6.09 0.09 (F = 0.01, P = 0.91)
 Perceived health compared with 1 year ago 2 (1.23) 2.05 (1.53) 2.02 0.05 (F = 0.01, P = 0.91)
 Perceived health compared with onset chronic pain 1.95 (1.33) 1.81 (1.47) 1.89 0.14 (F = 0.1, P = 0.75)
 Average pain (numerical rating scale 0-10) 6.36 (1.94) 6.23 (1.77) 6.3 0.13 (F= 0.06, P = 0.81)
 Back pain intensity (strongest pain in the past 6 mo) 8.18 (1.82) 8.27 (1.70) 8.23 0.09 (F = 0.03, P = 0.86)
 Pain-related active coping self-statement 37.14 (8.01) 31.45 (7.55) 5.86 5.69 (F = 5.86, P = 0.02)
 Pain-related negative coping self-statement 26.68 (9.68) 29.73 (11.04) 28.20 3.05 (F = 0.95, P = 0.34)
 Depressed mood (Allgemeine Depressionsskala) 21.09 (10.38) 22.00 (9.15) 21.53 0.91 (F = 0.09, P = 0.76)
 Functional capacity in % (FFbHR) 50.38 (26.32) 59.09 (21.69) 54.73 8.71 (F = 1.44, P = 0.24)
 Duration of amitriptyline intake (mo) 19.91 (24.64) 18.36 (24.00) 19.14 1.55 (F = 0.04, P = 0.83)
 Dosage of amitriptyline (mg) 48.91 (90.94) 49.95 (96.21) 92.52 1.04 (F = 2.61, P = 0.11)

Data are mean values (SD), n (%), or n. Bold indicates only pain-related active coping self-statement revealed significant differences between groups with significantly more active coping self-statements in the social learning group. 1). n = 20 in the control group because 2 participants did not fill out their age.